The weekly litigation news digest is live. Subscribe now

IP Verse

Botulinum Toxin Assay With Improved Sensitivity - EP3270162

The patent EP3270162 was granted to Biomadison on Aug 16, 2023. The application was originally filed on Aug 8, 2014 under application number EP17183975A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3270162

BIOMADISON
Application Number
EP17183975A
Filing Date
Aug 8, 2014
Status
Patent Maintained As Amended
Jul 14, 2023
Publication Date
Aug 16, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERZ PHARMAMar 30, 2021ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB -

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004191887
DESCRIPTIONUS2006134722
DESCRIPTIONUS2011033866
DESCRIPTIONUS7183066
DESCRIPTIONUS7208285
DESCRIPTIONWO2014060373
OPPOSITIONUS2006134722
OPPOSITIONUS2008064054
OPPOSITIONUS2010209955
OPPOSITIONWO2009035476
OPPOSITIONWO2012166943
OPPOSITIONWO2013103737
SEARCHWO2009014854
SEARCHWO2009035476
SEARCHWO2013103737

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents